Skip to content

Try premium free for 7 days.

Plans
TheDesperateTrader
Compare

DRUG vs TRDA

TheDesperateTrader.com· Side-by-side stock comparison

$DRUG vs $TRDA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.

$20.76
Price
$5.03
+1.2%
Day change
+1.4%
$202M
Market cap
$194M
—
P/E ratio
—
—
Dividend yield
—
8.5M
Free float
39.2M
99.9%
Institutional
83.19%
248K
Avg volume
467K
0.7x
Rel. volume
0.9x
3% of 52w
52-week range
7% of 52w
98
Scanner alerts 30d
77
Pharmaceutical Preparations
Sector
Pharmaceutical Preparations

DRUG vs TRDA: trend, levels and the market

One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.

$TRDA leads 4 of 5
Performance
-64%
1 year
-43%
-74.7%
vs S&P 500
-53.6%
-73.6%
3 months
-33.8%
-62.4%
1 month
+0.8%
Trend
Downtrend
Trend
Downtrend
$46.25 below
50-day avg
$5.46 below
$69.26 below
200-day avg
$8.36 below
Key levels
none nearby
Resistance
$5.51 +9.6%
none nearby
Loading zone
$4.72 -6.1%
none nearby
Support
none nearby
$DRUG$20.76
$TRDA$5.03
SupportLoading zoneResistancePrice
  • ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
  • ·Neither kept up with the market over the past year: DRUG -64% and TRDA -43%, against the S&P 500 at +10.6%.

Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.

DRUG vs TRDA: the quick read

  • ·DRUG is the larger company by market cap ($202M vs $194M).
  • ·DRUG has been more active on our scanner (98 vs 77 alerts in 30 days).
  • ·DRUG has the smaller float (8.5M vs 39.2M), which tends to mean sharper, more volatile moves.
  • ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
  • ·TRDA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
  • ·Both stay busy on our scanner, 98 and 77 unusual-volume alerts over 30 days, so neither is the quiet one here.
  • ·They are closely matched in size, within 4% of each other on market cap, which makes the rest of this table the interesting part.
  • ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.

Objective differences only. Not investment advice.

Watching DRUG or TRDA? Get each morning’s movers by email

Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Frequently asked questions

Everything you need to know comparing DRUG and TRDA on TheDesperateTrader.

Is DRUG or TRDA the better stock?
"Better" depends on your goal, and these two are not alike. DRUG is the larger company by market cap ($202M vs $194M). DRUG has been more active on our scanner (98 vs 77 alerts in 30 days). DRUG has the smaller float (8.5M vs 39.2M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
What is the difference between DRUG and TRDA?
The differences that matter: they are similar in size ($202M vs $194M); they trade at very different share prices ($20.76 vs $5.03); DRUG sits at 3% of its 52-week range against 7% for TRDA; our scanner flagged DRUG 98 times in the last 30 days against 77 for TRDA. Everything above is measured from the latest completed session and SEC filings.
Which of DRUG and TRDA is more active right now?
Right now DRUG is at about 0.7x its normal volume and TRDA is at about 0.9x, so TRDA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
Is DRUG or TRDA in the stronger trend?
DRUG is below its 50-day average of $46.25 and below its 200-day average of $69.26; TRDA is below its 50-day average of $5.46 and below its 200-day average of $8.36. TRDA leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
Is this comparison data live?
Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.

Trading DRUG or TRDA? Get real-time unusual-volume alerts the moment either one moves, free.

Sign up free
No card · 5 premium days

Explore the market

Free, live market tools. No account required to look.

Site GuideEvery page explained, and how to trade with itTop Stocks TodaySix ranked stocks, live charts, why each oneRegularsThe names that keep coming back to the top of the scannerDue DiligenceDeep dives on one ticker, traced to SEC filings and the tapeSuper PortfolioEvery big holding from 13F filings and corporate stakesFree Stock ScannersEvery scanner in one placeCaught EarlyWhat our scanner flagged before it ranHow It WorksOur data, methodology & accuracyTrading CalculatorsPosition size, profit & average downTrading Taxes ExplainedWash sales, trader status and what you oweStock Market TodayWhat’s actually moving right nowLow Float MoversWho traded their whole float todayBetting AgainstWho the market is short, and which funds hold putsOur Call RecordEvery name we posted and what it did next, losers includedStocks to WatchTop 10 to watch next session, with reasonsTrending StocksWhat’s moving & being searched nowStock Sectors & ThemesAI, crypto, energy, banks & 40 moreBiggest Gainers TodayTop gainers & most activeWhy Stocks Are MovingToday’s movers + the catalyst behind eachInsider BuyingStocks insiders are buying (Form 4)Biggest Losers TodayTop decliners & worst performersPremarket MoversTop gainers & losers before the bellGap ScannerBiggest gap ups & downs. Did it fill?After Hours MoversTop gainers & losers after the closeMost Active StocksHighest dollar-volume names52-Week Highs & LowsStocks making new highs & lowsStock SplitsUpcoming & recent, and what happened afterOversold StocksLowest RSI, mean-reversion watchLow Float StocksSmallest floats, squeeze watchMost Volatile StocksBiggest daily range by ATR%Most Shorted StocksHighest short % of floatShort Squeeze StocksTop squeeze candidates by scorePenny StocksMost active under $5Stocks Under $1Most active sub-$1 namesStocks Under $10Most active under $10Overbought StocksHighest RSI, extended / pullback watchWeekly MoversBiggest gainers & losers this weekStock ScreenerScan by price, volume & RVOLThe Money MapMarket cap added or wiped, by sectorSector PerformanceBest & worst sectors todayStore ClosuresRetail & restaurant stocks under pressureEarnings CalendarWho reports before open & after closeEarnings Next WeekThe week ahead, biggest names by dayMoving After EarningsBiggest post-earnings gainers & losersEconomic CalendarFOMC, CPI, jobs & market-moving dataDividend CalendarEx-dates, yields & buy-by datesIPO CalendarRecent & upcoming stock listingsDaily RecapHow each session played outRVOL ScannerLive unusual-volume alertsHalt ScannerLive trading halts & resumesStock Halts TodayHalted stocks + reasons & resumesMost-Halted StocksRanked: which stocks halt most, 30dLive AlertsThe real-time scanner feedSmart MoneyInsider buys, 5% stakes & 13FReddit RadarTrending tickers & top postsGoogle Search RadarStocks America is Googling nowMarket CalendarEconomic, earnings & dividends in oneCrypto PricesLive Bitcoin, Ethereum & top coinsCurrency ConverterExchange rates: EUR, GBP, JPY & moreMortgage RatesCurrent 30-year & 15-year ratesAI StocksThe AI buildout: chips, cloud & softwareSemiconductor StocksChipmakers & equipment, and why they move